Fluoxetine: Therapeutic and undesirable effects

Hospital Medicine

Volumn 59, Issue 8, 1998, Pages 622-626

  Cookson, John ^a   Duffett, Richard ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; BULIMIA; CHILD; DRUG INTERACTION; HUMAN; OBSESSIVE COMPULSIVE DISORDER; PANIC; REVIEW;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BULIMIA; CHILD; DRUG INTERACTIONS; FLUOXETINE; HUMANS; MONOAMINE OXIDASE INHIBITORS; OBSESSIVE-COMPULSIVE DISORDER; PANIC DISORDER; SEROTONIN UPTAKE INHIBITORS;

EID: 0032147850     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Anonymous (1992) Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group. Arch Gen Psychiatry 49: 139-47
2. Anderson I (1997) Lessons to be learnt from meta-analysis of newer vs older antidepressants. Adv Psychiatr Treatm 3: 58-63
3. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL (1996) Birth outcomes in pregnant women taking fluoxetine. N EnglJ Med 335: 1010-5
4. Clerc GE, Ruimy P, Verdeau-Palles J (1994) A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. Int Clin Psychopharmacol 9: 139-43
5. Cohn JB, Collins G, Ashbrook E, Wernicke JF (1989) A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol 4:313-22
6. Cohn JB, Wilcox C (1985) A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder. J Clin Psychiatry 46: 26-31
7. Dunlop SR, Dornseif BE, Wernicke JF, Potvin JH (1990) Pattern analysis shows beneficial effect of fluoxetine treatment in mild depression. Psychopharmacol Bull 26: 173-80
8. Emslie GJ, Rush J, Weinberg WA et al (1997) A doubleblind, randomised, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 54: 1031-7
9. Fisch C (1985) Effect of fluoxetine on the electrocardiogram. J Clin Psychiatry 46: 421
10. Goldstein DJ, Wilson MG, Thompson VL, Potvin JH, Rampey AH Jr ( 1995) Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group. Br J Psychiatry 166: 660-6
11. Gram LF ( 1994) Fluoxetine. N Engl J Med 331: 1354-61
12. Heiligenstein JH, Beasley CM Jr, Potvin JH (1993) Fluoxetine not associated with increased aggression in controlled clinical trials. Int Clin Psychopharmacol 8: 277-80
13. Henry JA (1992) Toxicity of antidepressants: comparisons with fluoxetine. Int Clin Psychopharmacol 6 (Suppl 6): 22-7
14. Lam RW, Gorman CP, Michalon M et al (1995) Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. Am J Psychiatry 152: 1765-70
15. Levine S, Deo R, Mahadevan K (1987) A comparative trial of a new antidepressant, fluoxetine. Br J Psychiatry 150: 653-5
16. Montgomery DB, Roberts A, Green M, Bullock T, Baldwin D, Montgomery SA (1994) Lack of efficacy of fluoxetine in recurrent brief depression and suicidal attempts. Eur Arch Psychiatry Clin Neurosci 244: 211-5
17. Montgomery SA (1989) Efficacy of fluoxetine as an antidepressant in the short and long term. Int Clin Psychopharmacol 4 (Suppl 1): 113-19
18. Montgomery SA, Roberts A (1994) SSRIs: well tolerated in the treatment of depression. Hum Psychopharmacol 9 (Suppl 1): 7-10
19. Montgomery SA, Mclntyre A, Osterheider M et al (1993) A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group. Eur Neuropsychopharmacol 3: 143-52
20. Nulman I, Rovet J, Stewart DE et al (1997) Neurodevelopment of children exposed in utero to antidepressant drugs. N EnglJ Med 336: 258-62
21. Rothschild AJ, Locke CA (1991) Reexposure to fluoxetine after serious suicide attempts by three patients: the role of akathisia. J Clin Psychiatry 52: 491-3
22. Schneier FR, Liebowitz MR, Davis SO et al (1990) Fluoxetine in panic disorder. J Clin Psychopharmacol 10: 119-21
23. Simon GE, VonKorff M, Heiligenstein JH et al (1996) Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants. JAMA 275: 1897-902
24. Stark P, Hardison CD (1985) A review of multicenter controlled studies of fluoxetine vs imipramine and placebo in outpatients with major depressive disorder. J Clin Psychiatry 46: 53-8
25. Teicher MH, Glod C, Cole JO (1990) Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 147: 207-10
26. Tollefson GD, Rampey AH Jr, Potvin JH et al (1994) A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 51: 559-67
27. Yoshida K, Smith B, Craiggs M, Kumar R (1998) Fluoxetine in breast milk and developmental outcome of breast fed infants. Br J Psychiatry 172: 175-9